Ultrasound molecular imaging by targeted microbubble contrast agents

Minerva Biotecnologica

Volumn 21, Issue 2, 2009, Pages 97-110

  Mancini, M ^a,b   Greco, A ^c   Speranza, A ^a   Salvatore, M ^d  

^a CNR   (Italy)

^b IRCCS SDN   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Diffusion magnetic resonance imaging; Microbubbles; Ultrasonography

Indexed keywords

AFO 150; ALBUMIN; ALBUNEX; BR 14; CARDIOSPHERE; CYANOACRYLATE; CYANOACRYLATE DERIVATIVE; ECHO CONTRAST MEDIUM; GALACTOSE; INTERCELLULAR ADHESION MOLECULE 1; LIPID; MICROMARKER; MONOCLONAL ANTIBODY; MRX 815; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; PADGEM PROTEIN; PB 127; PERFLEXANE; PERFLUBUTANE; PERFLUOROPENTANE; PERFLUTREN; PHOSPHOLIPID; POLYBUTYL 2 CYANOACRYLATE; POLYGLACTIN; POLYLACTIDE; POLYMER; QUANTISON; SHU 508; SHU 563A; SONOVIST; SONOVUE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CONTRAST ENHANCEMENT; ECHOGRAPHY; HUMAN; MICROBUBBLE; MOLECULAR IMAGING; NONHUMAN; REVIEW; ULTRASOUND;

EQUUS ASINUS;

EID: 70350061189     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Weeissleder R, Mahmood U. Molecular imaging. Radiology 2001;219:316-333
2. Hoffman JM, Gambhir SS. Molecular imaging: the vision and opportunity for radiology in the future. Radiology 2007;244:39-47. (Pubitemid 46981957)
3. Turnbull DH, Bloomfield TS, Baldwin HS, Foster FS, Joyner AL. Ultrasound backscatter microscope analysis of early mouse embryonic brain-development. Proc Natl Acad Sci USA 1995;92:2239-2243
4. Aristizabal O, Christopher DA, Foster FS, Turnbull DH. 40-MHz echocardiography scanner for cardiovascular assessment of mouse embryos. Ultrasound Med Biol 1998;24:1407-1417 (Pubitemid 29003663)
5. Srinivasan S, Baldwin HS, Aristizabal O, Kwee L, Labow M, Artman M et al. Noninvasive, in utero imaging of mouse embryonic heart development with 40-MHz echocardiography. Circulation 1998;98:912-918
6. Turnbull DH, Ramsay JA, Shivji GS, Bloomfield TS, From L, Sauder DN et al. Ultrasound backscatter microscope analysis of mouse melanoma progression. Ultrasound Med Biol 1996;22:845-853 (Pubitemid 26320196)
7. Olsson M, Campbell K, Turnbull DH. Specification of mouse telencephalic and mid-hindbrain progenitors following heterotopic ultrasound-guided embryonic transplantation. Neuron 1997;19:761-772 (Pubitemid 27471382)
8. Liu AM, Joyner AL, Turnbull DH. Alteration of limb and brain patterning in early mouse embryos by ultrasound guided injection of Shh-expressing cells. Mech Dev 1998;75:107-115
9. Gaiano N, Kohtz JD, Turnbull DH, Fishell G. A method for rapid gain-of-function studies in the mouse embryonic nervous system. Nat Neurosci 1999;2:812-819 (Pubitemid 30491174)
10. Gee MS, Saunders HM, Lee JC, Sanzo JF, Jenkins WT, Evans SM et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res 2001;61:2974-2982
11. Deng CX, Lizzi FL. A review of physical phenomena associated with ultrasonic contrast agents and illustrative clinical applications. Ultrasound Med Biol 2002;28:277-286
12. Goldberg BB. Role of contrast agents in ultrasonography. Appl Radiol 1997;27:4-7.
13. Goldberg BB, Liu JB, Forsberg F. Ultrasound contrast agents: A review. Ultrasound Med Biol 1994;20:319-333
14. de Jong N, Bouakaz A, Frinking PJA. Basic acoustic properties of microbubbles. Echocardiography 2002;19:229-240
15. Cohen JL, Cheirif J, Segar DS, Gillam LD, Gottdiener JS, Hausnerova E et al. Improved left ventricular endocardialborder delineation and opacification with Optison (fs069), a new echocardiographic contrast agent. Results of a phase III multicenter trial. J Am Coll Cardiol 1998;32:746-752 (Pubitemid 28435264)
16. Chomas JE, Dayton P, Allen J, Morgan K, Ferrara KW. Mechanisms of contrast agent destruction, IEEE Trans. Ultrason Ferroelectr Freq Control 2001;48:232-248
17. Torchilin VP. Handbook of targeted delivery of imaging agents. Boca Raton, FL: CRC Press; 1995.
18. Kremkau W. Diagnostic ultrasound. Philadelphia, PA: W. B. Saunders Co.; 1989.
19. Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH et al. A novel-site targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996;94:3334-3340
20. Larson SM. Improving the balance between treatment and diagnosis a role for radioimmunodetection. Cancer handbook of targeted delivery of imaging agents. Torchilin VP, editor. Boca Raton, FL: CRC Press; 1995.
21. Klibanov AL, Hughes MS, Marsh JN, HaU CS, Miller JG, Wible JH et al. Targeting of ultrasound contrast material: an in vitro feasibility study. Acta Radiol 1997;412(Suppl 1):113-120 (Pubitemid 127619170)
22. Dayton P, Klibanov A, Brandenburger G, Ferrara K. Acoustic radiation force in viva a mechanism to assist targeting of microbubbles. Ultrasound Med Biol 1999;25:1195-1201 (Pubitemid 29465793)
23. Weller GE, Wong MK, Modzelewski RA, Lu E, Klibanov AL, Wagner WR et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 2005;65:533-539
24. Lindner JR, Song J, Xu F, Klibanov AL, Singbartl K, Ley K et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000;102:2745-2750 (Pubitemid 30949253)
25. Bachmann C, Klibanov AL, Olson TS, Sonnenschein JR, Rivera-Nieves J, Cominelli F et al. Targeting Mucosal Addressin Cellular Adhesion Molecule (Madcam)-1 To Noninvasively Image Experimental Crohn's disease. Gastroenterology 2005;130:8-16. (Pubitemid 43049830)
26. Hauff P, Reinhardt M, Briel A, Debus N, Schirner M. Molecular targeting of lymph nodes with L-selectin ligand-specific US contrast agent: a feasibility study in mice and dogs. Radiology 2004;231:667-673 (Pubitemid 38668081)
27. Ellegala DB, Leong-Poi H, Carpenter JE, Klibanov AL, Kaul S, Shaffrey ME et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation 2003;108:336-341
28. Leong-Poi H, Christiansen J, Heppner P, Lewis CW, Klibanov AL, Kaul S et al. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation 2005;111:3248-3254 (Pubitemid 40874997)
29. Weiler GE, Wong MK, Modzelewski RA, Lu E, Klibanov AL, Wagner WR et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 2005;65:533-539
30. Rychak JJ, Graba J, Cheung AM, Mystry BS, Lindner JR, Kerbel RS et al. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging 2007;6:289-296 (Pubitemid 350013534)
31. Willmann JK, Lutz AM, Paulmurugan R, Patel MR, Chu P, Rosenberg J et al. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology 2008;248:936-944
32. Linker RA, Reinhardt M, Bendszus M, Ladewig G, Briel B, Schirner M et al. In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE). J Autoimm 2005;25:199-205.
33. Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 1998;98:1-5. (Pubitemid 28312070)
34. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998;18:842-851 (Pubitemid 28267666)
35. Hamilton AJ, Huang SL, Warnick D, Rabbat M, Kane B, Nagaraj A et al. Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol 2004;43:453-460 (Pubitemid 38167708)
36. Alonso A, Della Martina A, Stroick M, Fatar M, Griebe M, Pochon S et al. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke 2007;38:1508-1514 (Pubitemid 46684166)
37. Li X, Wang Z, Ran H, Li X, Yuan Q, Zheng Y, Ren J et al. Experimental research on therapeutic angiogenesis induced by hepatocyte growth factor directed by ultrasound-targeted microbubble destruction in rats. J Ultrasound Med 2008;27:453-460
38. Willmann JK, Paulmurugan R, Chen K, Gheysens O, Rodriguez-Porcel M, Lutz AM et al. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 2008;246:508-518
39. Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001;104:2107-2112 (Pubitemid 33027054)
40. Lindner JR, Dayton PA, Coggins MP, Ley K, Song J, Ferrara K et al. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 2000;102:531-538
41. Villanueva FS, Jankowski RJ, Manaugh C, Wagner WR. Albumin microbubble adherence to human coronary endothelium: implications for assessment of endothelial function using myocardial contrast echocardiography. J Am Coll Cardiol 1997;30:689-693 (Pubitemid 27397648)
42. Walzog B, Schuppan D, Heimpel C, Hafezimoghadam A, Gaehtgens P, Ley K. The leukocyte integral Mac-1 (Cd11b/ Cd18) contributes to binding of human granulocytes to collagen. Exp Cell Res 1995;218:28-38.
43. Davis GE. The Mac-1 and P150,95 Beta-2 integrins bind denatured proteins to mediate leukocyte cell substrate adhesion. Exp Cell Res 1992;200:242-252
44. Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996;93:672-682 (Pubitemid 26052452)
45. Stieger SM, Dayton PA, Borden MA, Caskey CF, Griffey SM, Wisner ER et al. Imaging of angiogenesis using CadenceTM contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging 2008;3:9-18.
46. Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Prog Cardiovasc Dis 2001;44:13-31.
47. Lindner JR, Coggins MP, Kaul S, Klibanov AL, Brandenburger GH, Ley K. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. Circulation 2000;101:668-675 (Pubitemid 30094739)
48. Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC et al. Microbubbles targeted to intercellular artery endothelial cells. Circulation 1998;98:1-5.
49. Kaufmann BA, Sanders JM, Christopher Davis, Xie A, Aldred P, Sarembock I et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 2007;116:276-284 (Pubitemid 47196563)
50. Denekamp J. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 1993;66:181-196 (Pubitemid 23096969)
51. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-1763
52. Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972;136:261-276
53. Gimbrone MA Jr, Cotran RS, Leapman SB, Folkman J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst 1974;52:413-427
54. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
55. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994;265:1582-1584 (Pubitemid 24308973)
56. Cockerill GW, Gamble JR, Vadas MA. Angiogenesis: models and modulators. Int Rev Cytol 1995;159:113-160.
57. Giatromanolaki A, Sivridis E, Koukourakis MI, Georgoulias V, Gatter KC, Harris AL. Intratumoral angiogenesis: a new prognostic indicator forstage I endometrial adenocarcinomas? Oncol Res 1999;11:205-212
58. Dazzi C, Cariello A, Maioli P, Solaini L, Scarpi E, Rosti G et al. Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer. Lung Cancer 1999;24:81-88
59. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993;55:371-374 (Pubitemid 23300581)
60. Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 1995;36:193-204.
61. Strohmeyer D, Rossing C, Strauss F, Bauerfiend A, Kaufmann O, Loening S. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer. Prostate 2000;42:26-33. (Pubitemid 30004872)
62. Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR et al. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Nat Cancer Inst 1996;88:1146-1151 (Pubitemid 26274608)
63. Wang S, Liu H, Ren L, Pan Y, Zhang Y. Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference. Neoplasia 2008;10:399-407.
64. Nayaha V, Stenback F. Angiogenesis and expression of angiogenic agents in uterine and ovarian carcinosarcomas APMIS 2008;116:107-117
65. Rajkumar SV, Leong T, Roche PC, Fonseca R. Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 2000;6:3111-3116 (Pubitemid 30637735)
66. Bellamy WT. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies. Semin Oncol 2001;28:551-559 (Pubitemid 33134414)
67. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-858 (Pubitemid 19162712)
68. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-447
69. McAuslan BR, Bender V, Reilly W, Moss BA. New functions of epidermal growth factor: stimulation of capillary endothelial cell migration and matrix dependent proliferation. Cell Biol Int Rep 1985;9:175-182
70. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18-32.
71. Rosen EM, Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ et al. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo. Symp Soc Exp Biol 1993;47:227-234
72. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997;57:963-969 (Pubitemid 27098025)
73. Li M, Zhang Y, Feurino LW, Wang K, Fisher WE, Brunicardi FC et al. Interleukin-8 increases vascular endothelial growth factor and neutropilin expression and stimulates ERK activation in human pancreatic cancer. Cancer Sci 2008;99:733-737
74. Frater-Schroder M, Risau W, Hallmann R, Gautschi P, Böhlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987;84:5277-5281 (Pubitemid 17129009)
75. Sharpe RJ, Byers HR, Scott CF, Bauer SI, Maione TE. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 1990;82:848-853
76. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 1990;247:77-79 (Pubitemid 20059941)
77. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993;122:497-511. (Pubitemid 23210475)
78. Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI. The 16-kilodalton Nterminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 1993;133:1292-1299 (Pubitemid 23267784)
79. Henriet P, Blavier L, Declerck YA. Tissue inhibitors of metalloproteinases (TLMP) in invasion and proliferation. APMIS 1999;107:111-119
80. Leong-Poi H, Christiansen J, Klibanov AL, Kaul S, Lindner JR. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to v-integrins. Circulation 2003;107:455-460 (Pubitemid 36158049)
81. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251:788-791
82. Keller MW, Spotnitz WD, Matthew TL, Glasheen WP, Watson DD, Kaul S. Intraoperative assessment of regional myocardial perfusion using quantitative myocardial contrast echocardiography: an experimental evaluation. J Am Coll Cardiol 1990;16:1267-1279 (Pubitemid 20378483)
83. Aoki M, Kawata H, Mayer JE Jr. Coronary endothelial injury by cold crystalloid cardioplegic solution in neonatal lambs. Circulation 1992;86(5 Suppl. II):346-351
84. Milhoan KA, Lane TA, Bloor CM. Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF. Am J Physiol 1992;263(3 Pt 2):H956-62.
85. Lewisx Weller GE, Villanueva FS, Tom EM, Wagner WR. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Biotechnol Bioeng 2005;92:780-788
86. Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 1998;98:1-5. (Pubitemid 28312070)
87. Birnbaum Y, Iakobishvili Z, Porter A, Hasdai D, Atar S, Siegel RJ et al. Microparticle-containing oncotic solutions augment in-vitro clot disruption by ultrasound. Thromb Res 2000;98:549-557 (Pubitemid 30433783)
88. Culp WC, Porter TR, McCowan TC, Roberson PK, James CA, Matchett WJ et al. Microbubble-augmented ultrasound declotting of thrombosed arteriovenous dialysis grafts in dogs. J Vasc Interv Radiol 2003;14:343-347
89. Pagola J, Ribo M, Alvarez-Sabin J, Lange M, Rubiera M, Molina CA. Timing of recanalization after microbubble-enhanced intravenous thrombolysis in basilar artery occlusion. Stroke 2007;38:2931-2934 (Pubitemid 350035685)
90. Nesser HJ, Karia DH, Tkalec W, Pandian NG. Therapeutic ultrasound in cardiology. Herz 2002;27:269-278
91. Francis CW, Onundarson PT, Carstensen EL, Blinc A, Meltzer RS. Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest 1992;90:2063-2068
92. Tachibana K, Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 1995;92:1148-1150
93. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332:1553-1559
94. Unger EC, McCreery TP, Sweitzer RH, Shen D, Wu G. in vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol 1998;81(Suppl.):58G-61G. (Pubitemid 28309282)
95. Alonso A, Della Martina A, Stroick M, Fatar M, Griebe M, Pochon S et al. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke 2007;38:1508-1514 (Pubitemid 46684166)
96. Unger EC, Wu Q, McGreery TP, Matsunaga TO. Thrombus-specific contrast agents for imaging and thrombolysis. In: Goldberg BB, Raichlen JS, Forsberg F, editors. Ultrasound contrast agents. basic principles and clinical applications London: Martin Dunitz Ltd; 2001;337-345
97. Lindner JR. Detection of inflamed plaques with contrast ultrasound. Am J Cardiol 2002;90:32L-5L.
98. Behm CZ, Kaufmann BA, Carr C, Lankford M, Sanders JM, Rose CE et al. Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation 2008;117:2902-2911 (Pubitemid 351787072)
99. Kassan DG, Lynch AM, Stiller MJ. Physical enhancement of dermatologic drug delivery: iontophoresis and phonophoresis. J Am Acad Dermatol 1996;34:657-666
100. Barnett SB, Terhanger Haargr, Ziskin MC, Nyborg WL, Maeda K, Bang J. Current Status of Research on Biophysical Effects of Ultrasound. Ultrasound Med Biol 1994;20:205-218 (Pubitemid 24148511)
101. Marmottant P, Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 2003;423:153-156 (Pubitemid 36569534)
102. Nyborg WL. Ultrasonic microstreaming and related phenomena. Br J Cancer 1982;45 (Suppl V):156-160
103. Brennen CE. Cavitation and bubble dynamics. New York, NY: Oxford University Press; 1995.
104. May DJ, Allen JS, Ferrara KW. Dynamics and fragmentation of thick-shelled microbubbles. IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control 2002;49): 1400-1410
105. Jenne J. Kavitation in biologischem Gewebe. Ultraschall in Med 2001;22:2007.
106. Skyba DM, Price RJ, Linka AZ, Skalak TC, Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998;98:290-293 (Pubitemid 28348049)
107. Nyborg WL. Biological effects of ultrasound: development of safety guidelines. Part II: general review. Ultrasound Med Biol 2001;27:301-333
108. Linder JR. Microbubbles in medical imaging: current applications and future directions. Nature Reviews Drug Discovery 2004;3:527-532 (Pubitemid 38807535)
109. Bekeredjian R, Chen SY, Grayburn PA, Shohet RV. Delivery of luciferase enzyme to the heart using ultrasound targeted microbubble destruction. J Am Coll Cardiol 2004;43:374a-74a.
110. Bekeredjian R, Chen SY, Frenkel PA, Grayburn PA, Shohet RV. Ultrasound targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003;108:1022-1026 (Pubitemid 37048235)
111. Manome Y, Nakamura M, Ohno T, Furuhata H. Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo. Hum Gene Ther 2000;11:1521-1528 (Pubitemid 30670604)
112. Endoh M, Koibuchi N, Sato M, Morishita R, Kanzaki T, Murata Y et al. Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol Ther 2002;5:501-508 (Pubitemid 34546079)
113. Barbarese E, Ho S-Y, D'Arrigo JS, Simon RH. Internalization of microbubbles by tumor cells in vivo and in vitro. J Neurooncol 1995;26:25-34.
114. Mesiwala AH, Farrell L, Wenzel HJ, Silbergeld DL, Crum LA, Winn HR et al. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med Biol 2002;28:389-400. (Pubitemid 34308920)
115. Cho CW, Liu Y, Cobb WN, Henthorn TK, Lillehei K, Christians U et al. Ultrasound-induced mild hyperthermia as a novel approach to increase drug uptake in brain microvessel endothelial cells. Pharm Res 2002;19:1123-1129 (Pubitemid 34984995)
116. Hynynen K, Mc Dannold N, Martin H, Jolesz FA, Vykhodtseva N. The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison (R)). Ultrasound Med Biol 2003;29:473-481 (Pubitemid 36434336)
117. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101-114
118. Mitragotri S, Kost J. Low-frequency sonophoresis. A review. Adv Drug Deliv Rev 2004;56:589-601.
119. Qian Z, Stoodley P, Pitt WG. The effect of low intensity ultrasound upon biofilm structure from confocal scanning laser microscopy observation. Biomaterials 1996;17:1975-1980 (Pubitemid 26328937)
120. Qian Z, Sagers RD, Pitt WG. Investigation of the mechanism of the bioacoustic effect. J Biomed Mater Res 1999;44:198-205.
121. Francis CW, Blinc A, Lee S, Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 1995;21:419-424
122. Suchkova V, Carsten EL, Francis CW. Ultrasound enhancement of fibrinolysis at frequencies of 27 to 100 kHz. Ultrasound Med Biol 2002;28:377-382 (Pubitemid 34308918)
123. Loverock P, Ter Haarg, Ormerod MG, Imrie PR. The effect of ultrasound on the cytoxicity of adriamycin. Brit J Radiol 1990;63:542-546
124. Rediske AM, Rapoport N, Pitt WG. Reducing bacterial resistance to antibiotics with ultrasound. Lett Appl Microbiol 1999;28:81-84 (Pubitemid 29051844)
125. Johnson LL, Peterson RV, Pitt WG. Treatment of bacterial biofilms on polymeric implants using antibiotics and ultrasound. J Biomat Sci Polymer Ed 1998;9:1177-1185
126. Qian Z, Sagers RD, Pitt WG. The effect of ultrasonic frequency upon enhanced killing of p. aeruginosa biofilms. Annals Biomed Eng 1997;25:69-76. (Pubitemid 27053909)